Abstract:Time span in literature: 1985-early 2024 Natural products play a key role in drug discovery, both as a direct source of drugs and as a starting point for the development of synthetic compounds. Most natural products are not suitable to be used as drugs without further modification due to insufficient activity or poor pharmacokinetic properties. Choosing what modifications to make requires an understanding of the compound's structure–activity relationships. Use of structure–activity relationships is commonplace and essential in medicinal chemistry campaigns applied to human-designed synthetic compounds. Structure–activity relationships have also been used to improve the properties of natural products, but several challenges still limit these efforts. Here, we review methods for studying the structure–activity relationships of natural products and their limitations. Specifically, we will discuss how synthesis, including total synthesis, late-stage derivatization, chemoenzymatic synthetic pathways, and engineering and genome mining of biosynthetic pathways can be used to produce natural product analogs and discuss the challenges of each of these approaches. Finally, we will discuss computational methods including machine learning methods for analyzing the relationship between biosynthetic genes and product activity, computer aided drug design techniques, and interpretable artificial intelligence approaches towards elucidating structure–activity relationships from models trained to predict bioactivity from chemical structure. Our focus will be on these latter topics as their applications for natural products have not been extensively reviewed. We suggest that these methods are all complementary to each other, and that only collaborative efforts using a combination of these techniques will result in a full understanding of the structure–activity relationships of natural products.

Chemoenzymatic approaches for exploring structure–activity relationship studies of bioactive natural products

Structure‐activity Relationship Approaches and Applications

Chemo-enzymatic synthesis of natural products and their analogs

Current Progress in the Chemoenzymatic Synthesis of Natural Products

Advances, opportunities, and challenges in methods for interrogating the structure activity relationships of natural products

Chemoenzymatic synthesis planning by evaluating the synthetic potential in biocatalysis and chemocatalysis

Chemoenzymatic synthesis of small molecule human therapeutics.

Redesigning Enzymes for Biocatalysis: Exploiting Structural Understanding for Improved Selectivity

Chemoenzymatic Synthesis of Steroidal Products: Recent Advances

Structure-driven protein engineering for production of valuable natural products

Computer-aided understanding and engineering of enzymatic selectivity

Recent advances in structure‐based enzyme engineering for functional reconstruction

[Computational analysis of structure-activity relationship of industrial enzymes]

One-pot chemoenzymatic syntheses of non-canonical amino acids

Chemoenzymatic Synthesis of Cylindrocyclophanes A and F and Merocyclophanes A and D.

Atomic Engineering of Single‐Atom Nanozymes for Biomedical Applications

Chemoenzymatic synthesis of macrocyclic peptides and polyketides via thioesterase-catalyzed macrocyclization

Medicinal Chemistry Strategies for the Modification of Bioactive Natural Products

Current State‐of‐the‐Art Toward Chemoenzymatic Synthesis of Polyketide Natural Products

Enabling Chemoenzymatic Strategies and Enzymes for Synthesizing Sialyl Glycans and Sialyl Glycoconjugates

Identification of bioactive compounds with popular single-atom modifications: Comprehensive analysis and implications for compound design